Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Condition(s):Alpha-1-antitrypsin Deficiency; Liver CirrhosisLast Updated:October 12, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Alpha-1-antitrypsin Deficiency; Liver CirrhosisLast Updated:October 12, 2021Terminated
Condition(s):EpilepsyLast Updated:June 4, 2019Completed
Condition(s):Bipolar DisorderLast Updated:March 3, 2023Terminated
Condition(s):Seizures, FocalLast Updated:September 19, 2017Completed
Condition(s):HealthyLast Updated:July 15, 2022Completed
Condition(s):HealthyLast Updated:June 7, 2022Completed
Condition(s):Traumatic Brain InjuryLast Updated:April 22, 2022Completed
Condition(s):Bipolar DepressionLast Updated:June 24, 2008Completed
Condition(s):HealthyLast Updated:August 22, 2022Completed
Condition(s):Healthy ParticipantsLast Updated:April 21, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.